123 related articles for article (PubMed ID: 21635707)
1. Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors.
Bazarov AV; Yaswen P
Breast Cancer Res; 2011 May; 13(3):308. PubMed ID: 21635707
[TBL] [Abstract][Full Text] [Related]
2. High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer.
Reynisdottir I; Arason A; Einarsdottir BO; Gunnarsson H; Staaf J; Vallon-Christersson J; Jonsson G; Ringnér M; Agnarsson BA; Olafsdottir K; Fagerholm R; Einarsdottir T; Johannesdottir G; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Cancer Med; 2013 Aug; 2(4):437-46. PubMed ID: 24156016
[TBL] [Abstract][Full Text] [Related]
3. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
Sircoulomb F; Nicolas N; Ferrari A; Finetti P; Bekhouche I; Rousselet E; Lonigro A; Adélaïde J; Baudelet E; Esteyriès S; Wicinski J; Audebert S; Charafe-Jauffret E; Jacquemier J; Lopez M; Borg JP; Sotiriou C; Popovici C; Bertucci F; Birnbaum D; Chaffanet M; Ginestier C
EMBO Mol Med; 2011 Mar; 3(3):153-66. PubMed ID: 21328542
[TBL] [Abstract][Full Text] [Related]
4. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.
Holland DG; Burleigh A; Git A; Goldgraben MA; Perez-Mancera PA; Chin SF; Hurtado A; Bruna A; Ali HR; Greenwood W; Dunning MJ; Samarajiwa S; Menon S; Rueda OM; Lynch AG; McKinney S; Ellis IO; Eaves CJ; Carroll JS; Curtis C; Aparicio S; Caldas C
EMBO Mol Med; 2011 Mar; 3(3):167-80. PubMed ID: 21337521
[TBL] [Abstract][Full Text] [Related]
5. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
[TBL] [Abstract][Full Text] [Related]
6. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
7. ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes.
Klæstad E; Sawicka JE; Engstrøm MJ; Ytterhus B; Valla M; Bofin AM
Breast Cancer Res Treat; 2021 Feb; 186(1):65-77. PubMed ID: 33389351
[TBL] [Abstract][Full Text] [Related]
8. [ZNF703: a novel oncogene involved in breast cancer].
Ginestier C; Sircoulomb F; Charafe-Jauffret E; Chaffanet M; Birnbaum D
Med Sci (Paris); 2011 Apr; 27(4):357-9. PubMed ID: 21524397
[No Abstract] [Full Text] [Related]
9. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
10. Integrated profiling of basal and luminal breast cancers.
Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
[TBL] [Abstract][Full Text] [Related]
11. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
[TBL] [Abstract][Full Text] [Related]
12. Engineering targeted chromosomal amplifications in human breast epithelial cells.
Springer S; Yi KH; Park J; Rajpurohit A; Price AJ; Lauring J
Breast Cancer Res Treat; 2015 Jul; 152(2):313-21. PubMed ID: 26099605
[TBL] [Abstract][Full Text] [Related]
13. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma.
Li K; Wang J; Han J; Lan Y; Xie C; Pan S; Liu L
Oncotarget; 2016 Nov; 7(46):76108-76117. PubMed ID: 27764785
[TBL] [Abstract][Full Text] [Related]
15. ZNF703 acts as an oncogene that promotes progression in gastric cancer.
Yang G; Ma F; Zhong M; Fang L; Peng Y; Xin X; Zhong J; Yuan F; Gu H; Zhu W; Zhang Y
Oncol Rep; 2014 Apr; 31(4):1877-82. PubMed ID: 24481460
[TBL] [Abstract][Full Text] [Related]
16. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.
Wang H; Xu H; Ma F; Zhan M; Yang X; Hua S; Li W; Li Y; Lu L
Cell Death Dis; 2020 Apr; 11(4):225. PubMed ID: 32269215
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract][Full Text] [Related]
19. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Bautista S; Theillet C
Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
[TBL] [Abstract][Full Text] [Related]
20. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
